Author
Listed:
- P. Šmerák
(3 Faculty of Medicine, Charles University, Prague; National Institute of Public Health, Prague, Czech Republic)
- H. Šestáková
(3 Faculty of Medicine, Charles University, Prague; National Institute of Public Health, Prague, Czech Republic)
- Z. Polívková
(3 Faculty of Medicine, Charles University, Prague; National Institute of Public Health, Prague, Czech Republic)
- I. Bárta
(3 Faculty of Medicine, Charles University, Prague; National Institute of Public Health, Prague, Czech Republic)
- B. Turek
(3 Faculty of Medicine, Charles University, Prague; National Institute of Public Health, Prague, Czech Republic)
- J. Bártová
(3 Faculty of Medicine, Charles University, Prague; National Institute of Public Health, Prague, Czech Republic)
- M. Langová
(3 Faculty of Medicine, Charles University, Prague; National Institute of Public Health, Prague, Czech Republic)
- M. Anděl
(3 Faculty of Medicine, Charles University, Prague; National Institute of Public Health, Prague, Czech Republic)
Abstract
Using the Ames bacterial mutagenicity test and an in vivo micronucleus test, we investigated the antigenotoxic effect of ellagic acid on the genotoxicity of three mutagens: amino-methylimidazo-quinoline (IQ), aflatoxin B1 (AFB1), and N-nitroso-N-methylurea (MNU). Ellagic acid is a naturally occurring phenolic compound which is found in a variety of soft fruits and vegetables. The effect of this compound on the immunosuppressive activity of mutagens was followed in vivo by the chemiluminescence test. In the Ames assay, ellagic acid at concentrations of 300 and 30 μg/plate demonstrably inhibits the mutagenic activity of two indirect mutagens: IQ and AFB1. The concentration of 300 μg/plate had the strongest effect on mutagenicity of all concentrations of IQ in strain TA98 of Salmonella typhimurium, whereas in strain TA100 concentration of 30 μg per dish of ellagic acid was more effective than 300 μg per plate. Also in combination with different concentrations of AFB1, ellagic acid proved to be a strong antimutagen. In this case the lower of the two effective concentrations - 30 μg/plate - had a much greater antimutagenic effect on both strains tested than 300 μg/plate. In combination with the direct mutagen MNU, ellagic acid did not show any marked antimutagenic effect at most of the concentrations tested in strain TA100. Only the highest concentrations of ellagic acid reduced the mutagenic effect of MNU weakly and only in combination with two lower concentrations of MNU. In the micronucleus test, three-day oral application of ellagic acid prior to the applicaton of AFB1, IQ, or MNU, respectively, markedly reduced the numbers of micronuclei induced by these three mutagens in polychromatophilic erythrocytes of mice. Chemiluminescence test with mouse granulocytes proved that ellagic acid not only prevents the inhibitory effects of mutagens on free oxygen radicals and hydrogen peroxide production, but that this production is stimulated by ellagic acid in combination with mutagens even to a greater extent than by ellagic acid alone. From these results we can deduce that ellagic acid repairs strong immunosuppressive effects of all mutagens applied.
Suggested Citation
P. Šmerák & H. Šestáková & Z. Polívková & I. Bárta & B. Turek & J. Bártová & M. Langová & M. Anděl, 2002.
"Antimutagenic effect of ellagic acid and its effect on the immune response in mice,"
Czech Journal of Food Sciences, Czech Academy of Agricultural Sciences, vol. 20(5), pages 181-191.
Handle:
RePEc:caa:jnlcjf:v:20:y:2002:i:5:id:3530-cjfs
DOI: 10.17221/3530-CJFS
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:caa:jnlcjf:v:20:y:2002:i:5:id:3530-cjfs. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Ivo Andrle (email available below). General contact details of provider: https://www.cazv.cz/en/home/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.